Minoxidil
| Clinical data | |
|---|---|
| Trade names | Loniten, Rogaine, others |
| Other names | U-10858; U-10,858; U10858; 2,4-Diamino-6-piperidinopyrimidine 3-oxide |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682608 |
| License data | |
| Pregnancy category |
|
| Routes of administration | Oral, sublingual, topical (solution, foam, spray) |
| Drug class | Potassium channel opener; KATP channel opener |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | Oral: ≥90% (absorption) Topical: ~1.2–1.4% |
| Protein binding | Minimal or negligible |
| Metabolism | Primarily liver via glucuronidation, hydroxylation, and sulfation (SULT1A1, SULT2A1) |
| Metabolites | • Minoxidil glucuronide • Minoxidil sulfate |
| Onset of action | Oral: 30–60 minutes (peak) Sublingual: 30 minutes |
| Elimination half-life | Oral: 3–4 hours Topical: 22 hours |
| Duration of action | Oral: ~72 hours Topical: 10–12 hours |
| Excretion | Urine: >97% (10–15% unchanged; within 12–20 hours for oral and 4 days for topical) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| PDB ligand | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.048.959 |
| Chemical and physical data | |
| Formula | C9H15N5O |
| Molar mass | 209.253 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 248 °C (478 °F) |
| Solubility in water | < 1 |
| |
| |
Minoxidil, sold under the brand names Loniten and Rogaine among others, is a medication used for the treatment of high blood pressure and pattern hair loss. It is an antihypertensive and a vasodilator. It is available as a generic medication by prescription in oral tablet form and over-the-counter as a topical liquid or foam.